CCXI Stock Quote - ChemoCentryx, Inc. Stock Price Today CCXI stock quote, chart and news. Get ChemoCentryx, Inc.'s stock price today. ChemoCentryx (CCXI) Stock Could Hit $40, Says Analyst Nov 26, 2019 · Although ChemoCentryx has only a few analysts currently throwing the hat in the ring, all are bullish on the stock. CCXI’s analyst consensus rating is a Strong Buy, with all 3 analysts giving it CCXI - Chemocentryx News - Barchart.com
ChemoCentryx Inc - Company Profile and News - Bloomberg ...
CCXI | Complete ChemoCentryx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat CCXI's price/sales ratio is 67.02; that's higher than the P/S ratio of 98.02% of US stocks. Revenue growth over the past 12 months for ChemoCentryx Inc comes ChemoCentryx, Inc. Common Stock (CCXI) Stock Quotes - Nasdaq offers stock quotes Latest News. 7 “Perfect 10” Healthcare Stocks to Buy Now Mar 18, 2020 . Prev Close 43.50, 52 Wk Low 6.16. Open 44.94, 52 Wk High 51.36. Day Low 42.41, Volume 97,393.00. Day High 45.13, Avg 10D Vol 607,289.00 Analyzing ChemoCentryx (NASDAQ:CCXI) stock? View CCXI's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at We apologize for any inconvenience. Refresh or try again later. Summary. News. Profile. Financials. Events. Ownership. Options
CCXI -- Is Its Stock Price A Worthy Investment? Learn More.
ChemoCentryx, Inc. Common Stock (CCXI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
ChemoCentryx Inc. Stock Price (CCXI) | Barron's
Analyzing ChemoCentryx (NASDAQ:CCXI) stock? View CCXI's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at We apologize for any inconvenience. Refresh or try again later. Summary. News. Profile. Financials. Events. Ownership. Options Stock Price Forecast. The 6 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 60.50, with a high estimate of 64.00 and a Feb 6, 2020 Chemocentryx Inc (CCXI) President and CEO Thomas J. Schall Sold $5.4 million of Shares, Stocks: CCXI, release date:Feb 06, 2020. Nov 26, 2019 After the news broke, CCXI stock skyrocketed by as much as 325% to $34.32 and now is the biggest gainer in the biotech sector. Moreover, the Company Name: ChemoCentryx, Stock Symbol: CCXI, Industry: Biotechs, Total Posts: 203, Last Post: 12/9/2019 7:49:38 PM. About CCXI. ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory
Get breaking news and analysis on ChemoCentryx, Inc. (CCXI) stock, price quote and chart, trading and investing tools.
Toy donations will be accepted at #CCXI! UPDATE: Seats just added to #CCXI tomorrow!! US Banking News @AmericanBanking 17 Apr 2018 http://bit.ly/ Stock-Alerts Benzinga's Top #PreMarket Gainers http://dlvr.it/4RfYMy #CAMT
Shares of ChemoCentryx Inc. (CCXI) skyrocketed in extended trading on Monday, following positive topline data from a phase III trial of Avacopan for the treatment of patients with anti-neutrophil ChemoCentryx Inc - Company Profile and News - Bloomberg ...